Taylor Wesley
Physician Assistant · Moberly, MONPI 1598209512
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 412 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 412 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$883
- Novo Nordisk$759
- Amgen$705
- Abbott$561
- Lilly USA, LLC$393
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,89599%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 96 | $1,281 |
| AstraZeneca | 34 | $883 |
| Novo Nordisk | 55 | $759 |
| Amgen | 39 | $705 |
| Abbott | 25 | $561 |
| Lilly USA, LLC | 26 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $274 |
| Pfizer | 18 | $247 |
| Bayer | 12 | $236 |
| Otsuka America Pharmaceutical, Inc. | 10 | $189 |
| Axsome Therapeutics, Inc. | 9 | $183 |
| Lundbeck LLC | 8 | $156 |
| Biohaven Pharmaceuticals, Inc. | 15 | $155 |
| Exact Sciences | 7 | $120 |
| Merck | 4 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $64 |
| Novartis | 3 | $63 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Dexcom, Inc. | 3 | $56 |
| Ardelyx, Inc. | 2 | $46 |
| Boehringer Ingelheim | 3 | $44 |
| Nevro Corp. | 3 | $41 |
| Viatris Specialty LLC | 2 | $38 |
| Verona Pharma, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $34 |
| Biocryst US Sales Co., LLC | 1 | $31 |
| GSK | 2 | $29 |
| Johnson & Johnson | 2 | $27 |
| Insulet Corporation | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$315
- BREZTRI$315
- AIRSUPRA$315
- FREESTYLE LIBRE 3$130
How this compares
$6,931 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 182 | $193,676 |
| FarxigaDapagliflozin Propanediol | 180 | $134,420 |
| MounjaroTirzepatide | 64 | $86,464 |
| EliquisApixaban | 84 | $65,703 |
| Repatha SureclickEvolocumab | 91 | $61,878 |
| TrulicityDulaglutide | 40 | $41,416 |
| Nurtec OdtRimegepant Sulfate | 20 | $26,473 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $25,467 |
| RexultiBrexpiprazole | 17 | $23,295 |
| MyrbetriqMirabegron | 42 | $23,042 |
| Breo ElliptaFluticasone/Vilanterol | 50 | $22,143 |
| VraylarCariprazine Hcl | 15 | $21,546 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $17,602 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 35 | $17,268 |
| JardianceEmpagliflozin | 18 | $16,954 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $759 | $193,676182 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $883 | $152,021208 claims |
| Lilly USA, LLCMounjaro, Trulicity | $393 | $127,880104 claims |
| PfizerEliquis, Nurtec Odt | $247 | $92,175104 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arexvy | $29 | $73,675153 claims |
| AbbVieVraylar, Ubrelvy, Qulipta, Linzess | $1,281 | $59,59755 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $189 | $23,29517 claims |
| Boehringer IngelheimJardiance | $44 | $16,95418 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $274 | $5,91412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.
Other physician assistant in Moberly
- Jennifer DavissonKansas City$343K
- Andrew BergLees Summit$245K
- Sileen DowisKansas City$117K
- Daniel BeckSikeston$114K
- Amee RozancO Fallon$101K
- Autumn WillsCape Girardeau$37K
- Kimberly BrownSaint Louis$28K
- Marc ReitznerSpringfield$24K
- Justin AllphinOzark$23K
- Jacqueline CastagnoWentzville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.